{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:09:44Z","timestamp":1761091784829,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2000,6,1]],"date-time":"2000-06-01T00:00:00Z","timestamp":959817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2000,6,1]],"date-time":"2000-06-01T00:00:00Z","timestamp":959817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":4794,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2000,6]]},"DOI":"10.1053\/seiz.2000.0397","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T10:55:08Z","timestamp":1032432908000},"page":"287-290","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Recovery of visual field constriction following discontinuation of vigabatrin"],"prefix":"10.1053","volume":"9","author":[{"given":"K.","family":"Krakow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Polizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Riordan-Eva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Holder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.N.","family":"MacLeod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.R.","family":"Fish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/seiz.2000.0397_RF1","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/bmj.314.7075.180","article-title":"Severe persistent visual field constriction associated with vigabatrin","volume":"314","author":"Eke","year":"1997","journal-title":"British Medical Journal"},{"key":"10.1053\/seiz.2000.0397_RF2","first-page":"1694","article-title":"Four possible explanations exist","volume":"314","author":"Harding","year":"1997","journal-title":"British Medical Journal"},{"key":"10.1053\/seiz.2000.0397_RF3","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1136\/bmj.314.7095.1693a","article-title":"Chronic refractory epilepsy may have role in causing these unusual lesions","volume":"314","author":"Wilson","year":"1997","journal-title":"British Medical Journal"},{"key":"10.1053\/seiz.2000.0397_RF4","first-page":"1694","article-title":"Reaction might be dose dependent","volume":"314","author":"Wong","year":"1997","journal-title":"British Medical Journal"},{"key":"10.1053\/seiz.2000.0397_RF5","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1212\/WNL.52.6.1201","article-title":"Outer retinal dysfunction in patients treated with vigabatrin","volume":"52","author":"Arndt","year":"1999","journal-title":"Neurology"},{"key":"10.1053\/seiz.2000.0397_RF6","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1212\/WNL.53.5.922","article-title":"Vigabatrin, a gabaergic antiepileptic drug, causes concentric visual field defects","volume":"53","author":"K\u00e4lvi\u00e4inen","year":"1999","journal-title":"Neurology"},{"key":"10.1053\/seiz.2000.0397_RF7","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1136\/bmj.317.7168.1322","article-title":"Guideline may help in prescribing vigabatrin","volume":"317","author":"Appleton","year":"1998","journal-title":"British Medical Journal"},{"key":"10.1053\/seiz.2000.0397_RF8","first-page":"122","article-title":"Allergische Vaskulitis durch Vigabatrin","volume":"65","author":"Dieterle","year":"1994","journal-title":"Nervenarzt"},{"key":"10.1053\/seiz.2000.0397_RF9","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0140-6736(99)02095-4","article-title":"Reversibility of vigabatrin-induced visual-field defect","volume":"354","author":"Versino","year":"1999","journal-title":"Lancet"},{"key":"10.1053\/seiz.2000.0397_RF10","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1212\/WNL.50.3.614","article-title":"Vigabatrin-associated retinal cone system dysfunction","volume":"50","author":"Krauss","year":"1998","journal-title":"Neurology"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131100903972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131100903972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:25:16Z","timestamp":1761009916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131100903972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,6]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,6]]}},"alternative-id":["S1059131100903972"],"URL":"https:\/\/doi.org\/10.1053\/seiz.2000.0397","relation":{},"ISSN":["1059-1311"],"issn-type":[{"type":"print","value":"1059-1311"}],"subject":[],"published":{"date-parts":[[2000,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recovery of visual field constriction following discontinuation of vigabatrin","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/seiz.2000.0397","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2000 BEA Trading, Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}